Canada Markets open in 5 hrs 33 mins
  • S&P/TSX

    20,491.01
    +284.60 (+1.41%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • DOW

    32,654.59
    +431.17 (+1.34%)
     
  • CAD/USD

    0.7791
    -0.0018 (-0.2244%)
     
  • CRUDE OIL

    113.97
    +1.57 (+1.40%)
     
  • BTC-CAD

    38,295.94
    -960.52 (-2.45%)
     
  • CMC Crypto 200

    669.80
    +427.12 (+176.00%)
     
  • GOLD FUTURES

    1,813.10
    -5.80 (-0.32%)
     
  • RUSSELL 2000

    1,840.30
    +56.87 (+3.19%)
     
  • 10-Yr Bond

    2.9680
    0.0000 (0.00%)
     
  • NASDAQ futures

    12,475.50
    -84.75 (-0.67%)
     
  • VOLATILITY

    26.66
    -0.81 (-2.95%)
     
  • FTSE

    7,512.84
    -5.51 (-0.07%)
     
  • NIKKEI 225

    26,911.20
    +251.45 (+0.94%)
     
  • CAD/EUR

    0.7404
    +0.0007 (+0.09%)
     

Stocks in play: PharmaTher Inc

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Is pleased to provide an update on the Company’s psilocybin pharmaceutical development programs. The Company is evaluating psilocybin as a potential treatment for methamphetamine use disorder with the University of Wisconsin-Madison through a clinical trial agreement. PharmaTher Inc shares C.PHRM are trading unchanged at $0.34.

Read:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting